Study Findings Suggest that WAYLIVRA Could be an Effective Treatment for Familial Partial Lipodystrophy
Bru-nO / Pixabay

Study Findings Suggest that WAYLIVRA Could be an Effective Treatment for Familial Partial Lipodystrophy

According to a story from globenewswire.com, Akcea Therapeutics and Ionis Pharmaceuticals recently announced the release of top line results from a clinical study. This trial tested the drug WAYLIVRA as…

Continue Reading Study Findings Suggest that WAYLIVRA Could be an Effective Treatment for Familial Partial Lipodystrophy

New Treatment for Familial Chylomicronemia Syndrome is Close to Approval in the EU

Familial Chylomicronemia Syndrome Familial chylomicronemia syndrome (FCS) is a condition that is considered ultra-rare. It's caused when the enzyme called lipoprotein lipase (LPL) is impaired. It is can result in…

Continue Reading New Treatment for Familial Chylomicronemia Syndrome is Close to Approval in the EU
Worried About hATTR Amyloidosis? Check Out This New Genetic Testing Program
Source: Pixabay

Worried About hATTR Amyloidosis? Check Out This New Genetic Testing Program

According to Globe Newswire, a pharmaceutical company, Akcea Therapeutics, recently announced their new genetic testing and counseling treatment program for those who may have hereditary ATTR amyloidosis (hATTR amyloidosis). The program,…

Continue Reading Worried About hATTR Amyloidosis? Check Out This New Genetic Testing Program
College Student with Lipodystrophy Advocates for a Change in Genetic Testing
Source: Pixabay

College Student with Lipodystrophy Advocates for a Change in Genetic Testing

Dena Winchester, a sophomore at Rutgers University, faces the struggles that come with her condition by advocating for change, reports New Jersey Jewish News. After she was diagnosed with lipodystrophy…

Continue Reading College Student with Lipodystrophy Advocates for a Change in Genetic Testing
Close Menu